Merck比收入估计数高,但损失了收入;维持2025年的指导和红利。 Merck beats earnings estimates but misses revenue; maintains 2025 guidance and dividend.

Merck & Co.公司报告说,第二季度的强劲收入为每股2.13美元,估计增加0.10美元,尽管收入为158.1亿美元,略微超出预期。 Merck & Co. reported strong second-quarter earnings of $2.13 per share, beating estimates by $0.10, though revenue of $15.81 billion slightly missed expectations. 该公司将2025年的全年指导维持在每股8.87至8.97美元之间,并宣布季度红利为0.81美元,收益率为3.9%。 The company maintained its 2025 full-year guidance at $8.87–$8.97 per share and declared a quarterly dividend of $0.81, yielding 3.9%. 包括多拉山第一国家银行和财富计划投资管理公司在内的机构投资者调整了他们的股权,而分析师则给予混合评级,从而形成协商一致的“持股”,目标价格为104.33美元。 Institutional investors, including First National Bank of Mount Dora and WealthPlan Investment Management, adjusted their stakes, while analysts issued mixed ratings, resulting in a consensus "hold" with a $104.33 target price. 股票交易额为83.72美元,市场上限为209.11亿美元,P/E比率为12.90。 The stock traded at $83.72, with a market cap of $209.11 billion and a P/E ratio of 12.90.